() managing director & CEO Sean Hall catches up with Proactive Investors about the biotech's progress so far in 2019.
Hall teases, "We're planning on having around about 3000 pharmacies utilising the Medlab VMS range before this calendar year is out."
Progress is also being made with the NanoCelle drug delivery platform. Clinical and human trials are ongoing for NanaBis and NanoStat. On the back of this, Medlab has been making strong moves into Europe.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Medlab Clinical Ltd named herein, including the promotion by the Company of Medlab Clinical Ltd in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE